These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16274052)

  • 1. [Update in the research of gene therapy for pancreatic carcinoma].
    Wang M; Wang YL; Lei RQ; Feng DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):648-53. PubMed ID: 16274052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene therapy in pancreatic cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2004 Feb; 145(5):211-5. PubMed ID: 15024931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy developments for pancreatic cancer.
    Bhattacharyya M; Lemoine NR
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular target-based therapy of pancreatic cancer.
    Lebedeva IV; Sarkar D; Su ZZ; Gopalkrishnan RV; Athar M; Randolph A; Valerie K; Dent P; Fisher PB
    Cancer Res; 2006 Feb; 66(4):2403-13. PubMed ID: 16489047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of molecular biology studies to gene therapy treatment strategies.
    Gustin A; Pederson L; Miller R; Chan C; Vickers SM
    World J Surg; 2002 Jul; 26(7):854-60. PubMed ID: 11960211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of gene therapy for pancreatic cancer.
    Ramírez PJ; Vickers SM
    Curr Surg; 2004; 61(1):84-92. PubMed ID: 14972178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
    Talar-Wojnarowska R; Malecka-Panas E
    Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pancreatic carcinoma: conclusive clinical consequences based on molecular biology knowledge for therapy].
    Ketterer K; Friess H; Büchler MW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():405-10. PubMed ID: 9931650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral gene therapy for pancreatic cancer: where do we stand?
    Kuhlmann KF; Gouma DJ; Wesseling JG
    Dig Surg; 2008; 25(4):278-92. PubMed ID: 18635930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic adjuvant therapy for pancreatic cancer and other solid tumours.
    Bagley KC
    Gut; 2008 Mar; 57(3):289-91. PubMed ID: 18268052
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present status of and prospects for basic research on pancreatic cancer].
    Zhao YP; Zhang TP
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1945-7. PubMed ID: 19062731
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
    Roy P; Waxman DJ
    Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of pancreatic cancer.
    Maitra A; Kern SE; Hruban RH
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular aspects of carcinogenesis in pancreatic cancer.
    Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
    Deharvengt S; Rejiba S; Wack S; Aprahamian M; Hajri A
    Int J Oncol; 2007 Jun; 30(6):1397-406. PubMed ID: 17487360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New molecular targets in pancreatic cancer].
    Torrisani J; Bournet B; Cordelier P; Buscail L
    Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
    Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
    Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for pancreatic and biliary malignancies.
    Aspinall RJ; Lemoine NR
    Ann Oncol; 1999; 10 Suppl 4():188-92. PubMed ID: 10436819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
    Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
    J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
    Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG
    Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.